BridgeBio Pharma Inc (NASDAQ:BBIO)

6.74
Delayed Data
As of May 16
 +0.12 / +1.81%
Today’s Change
4.98
Today|||52-Week Range
65.33
-59.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2017

2018

--

--
Revenue and IncomeNet Revenues0.000.00------
Depreciation And Amortization260.0K245.0K----
 
 
 
 
Operating ExpensesGross Income-260.0K-245.0K----
 
 
 
General Expenses43.6M183.4M----
 
 
 
Research And Development30.6M140.1M----
 
 
 
Total Operating Expenses43.9M183.7M----
 
 
 
 
Non-Operating ExpensesOperating Income-43.9M-183.7M----
 
 
 
Extraordinary Credit0.0019.1M----
 
 
Interest Expense On Debt13.0K2.5M----
 
 
 
Other Expenses0.00-4.3M----
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-43.8M-169.5M----
 
 
 
Minority Interest-13.3M-38.7M----
 
 
 
Preferred Dividend-5.7M-13.3M----
 
 
 
Net Income-30.6M-130.7M----
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS117.2M123.0M----
 
 
 
Shares To Calculate EPS Diluted117.2M123.0M----
 
 
 
 
Earnings Per ShareEPS-$0.31-$1.17----
 
 
 
EPS Diluted-$0.31-$1.17----